The Q2 22 results were disappointing, particularly at the topline level
Margins remain high, but the group has so far failed to return to growth
The mid-term targets do not seem to be at risk at this stage, but patience is required
We give the group the benefit of the doubt… so far
27 Jul 2022
Q2 22: the resumption of growth is postponed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q2 22: the resumption of growth is postponed
- Published:
27 Jul 2022 -
Author:
Fabrice Farigoule -
Pages:
3
The Q2 22 results were disappointing, particularly at the topline level
Margins remain high, but the group has so far failed to return to growth
The mid-term targets do not seem to be at risk at this stage, but patience is required
We give the group the benefit of the doubt… so far